Minas Americas · Metallurgy and product pathway
Grade attracts attention. Recovery decides whether it matters.
Minas Americas has reported head-grade assays and an initial diagnostic solution response. The next phase will measure representative extraction, impurity behaviour, mass balance and the route to a potential product.
What the diagnostic screen measured
From selected clay sample to solution analysis.
The screen measured rare-earth concentrations in primary leach solution and set the starting point for representative recovery work.
-
01Solid inputSelected interval sample
Prepared, screened laboratory material. The total head assay is a separate measurement of the solid.
Head assay matrix · ppm in solid -
02Defined conditionSingle laboratory contact
Ammonium ions exchange with some surface-bound rare-earth ions under one stated test condition.
Diagnostic test · not a plant flowsheet -
03Liquid outputPrimary leach solution
The liquid after contact is collected as PLS. It is a test solution, not a product.
Solid residue · required for full mass balance -
04Measured resultICP-MS solution analysis
Elements measured in PLS are expressed as oxide-equivalent DREO totals, including the MREO subset.
Diagnostic result · mg/kg of PLS
Some rare-earth elements entered solution under the stated condition, supporting ionic-adsorption behaviour in the selected tested samples.
Extraction or recovery percentage, representativeness, complete mass balance, a commercial flowsheet, a product specification or project economics.
Selected diagnostic screening; not optimised. DREO = desorbable rare-earth oxides. MREO = Nd, Pr, Dy and Tb oxides. Sources: SGS certificate GQ2509212 and technical disclosure dated 21 October 2025. Solution concentration is not recovery.
Selected shallow diagnostic leach results

Accessible data transcript (HTML)
Five selected shallow intervals tested using SGS ICM694: 0.5 M ammonium sulphate, nominal pH 4 and 30 minutes.
| Interval | MREO in solution | DREO in solution | MREO share of DREO |
|---|---|---|---|
| PT-34 · 0-1 m | 161 mg/kg | 383 mg/kg | 41.9% |
| PT-34 · 1-2 m | 240 mg/kg | 578 mg/kg | 41.6% |
| PT-36 · 0-1 m | 278 mg/kg | 667 mg/kg | 41.6% |
| PT-42 · 0-1 m | 167 mg/kg | 383 mg/kg | 43.6% |
| MAV_AD_0002 · 2-3 m | 237 mg/kg | 492 mg/kg | 48.1% |
Selected diagnostic results, not optimised or representative recovery tests. Values are solution concentrations, not recovery percentages. MREO comprises Nd, Pr, Dy and Tb oxides; DREO is expressed on an oxide-equivalent basis.
From assay to payability
Five distinct measures from rock to revenue.
Each step answers a different question, from what is present to what can be recovered, made and sold.
- 01
Head grade
What the original solid sample contains before processing. The June drilling results are head-grade assays.
- 02
Diagnostic solution result
What dissolved under one defined laboratory test. This is where the selected 2025 work sits.
- 03
Extraction or desorption percentage
The measured share of the original inventory transferred into solution, supported by sample mass, solution volume and mass balance.
- 04
Full flowsheet recovery
The share reaching a defined product after each process stage, including losses and recycle streams.
- 05
Payable recovery
The portion for which a customer would pay after specifications, impurities and commercial deductions.
A solid head assay and a concentration reported in mg/kg in solution cannot be divided to calculate recovery without the original sample mass, solution volume, solids-to-liquid ratio and complete mass balance.
Process streams
Build the complete flowsheet picture.
Representative work will reconcile rare earths and impurities across feed, solution, residue, losses and the selected product route.
Radiological evidence
Build the complete radiological picture.
In three selected 2025 primary leach solutions, uranium was reported below 0.04 mg/kg in every result; thorium was reported at 2.59 mg/kg, below 0.20 mg/kg and 2.92 mg/kg.
The next step is representative feed–solution–residue–product characterisation with a complete mass balance and appropriate radiological measurements.
Product pathway
First define a product. Then test whether a customer can use it.
Representative mineralogy, element-by-element extraction, impurity behaviour and mass balance must come before a defensible product concept.
Only then can Magnes and potential partners assess purification, separation, qualification, realised pricing, capital and operating implications.
Discuss a relevant capabilityInvestment case
See how metallurgy changes the thesis.
Representative recovery, impurities and product definition will determine how much of the geological result can matter commercially.
See what changes the thesis